Amedeo Smart

Free Medical Literature Service

 

Amedeo

Prostate Cancer
  Free Subscription

Articles published in
JAMA
    November 2024
  1. AJJAWI I, Loeb S, Cooperberg MR, Catalona WJ, et al
    Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer, 2010-2020.
    JAMA. 2024 Nov 20:e2420580. doi: 10.1001/jama.2024.20580.
    >> Share

    August 2024
  2. TURNER EL, Metcalfe C, Martin RM
    PSA Screening and Prostate Cancer Mortality-Reply.
    JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13809.
    >> Share

  3. GOLDSTEIN MR, Mascitelli L
    PSA Screening and Prostate Cancer Mortality.
    JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13806.
    >> Share

  4. D'AMICO AV
    PSA Screening and Prostate Cancer Mortality.
    JAMA. 2024 Aug 15. doi: 10.1001/jama.2024.13803.
    >> Share

    July 2024
  5. NIK-AHD F, De Hoedt AM, Butler C, Anger JT, et al
    Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen.
    JAMA. 2024;332:335-337.
    >> Share

    June 2024
  6. FENG X, Zahed H, Onwuka J, Callister MEJ, et al
    Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis.
    JAMA. 2024;331:1910-1917.
    >> Share

    May 2024
  7. NEWCOMB LF, Schenk JM, Zheng Y, Liu M, et al
    Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
    JAMA. 2024 May 30. doi: 10.1001/jama.2024.6695.
    >> Share

  8. HARRIS E
    Urine-Based Test Could Help Identify Aggressive Prostate Cancer.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.8424.
    >> Share

  9. HARRIS E
    Prostate Cancer Cases Might Rise to 3 Million Globally by 2040.
    JAMA. 2024 May 3. doi: 10.1001/jama.2024.6729.
    >> Share

    April 2024
  10. BAROCAS DA, Al Hussein Al Awamlh B, Koyama T
    Outcomes Following Localized Prostate Cancer Treatment-Reply.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5492.
    >> Share

  11. HUANG TB, Ding XF
    Outcomes Following Localized Prostate Cancer Treatment.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5486.
    >> Share

  12. CORNU JN
    Outcomes Following Localized Prostate Cancer Treatment.
    JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5489.
    >> Share

  13. AUVINEN A, Tammela TLJ, Mirtti T, Lilja H, et al
    Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial.
    JAMA. 2024 Apr 6:e243841. doi: 10.1001/jama.2024.3841.
    >> Share

  14. TOSOIAN JJ, Penson DF, Chinnaiyan AM
    A Pragmatic Approach to Prostate Cancer Screening.
    JAMA. 2024 Apr 6. doi: 10.1001/jama.2024.4089.
    >> Share

  15. MARTIN RM, Turner EL, Young GJ, Metcalfe C, et al
    Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
    JAMA. 2024 Apr 6:e244011. doi: 10.1001/jama.2024.4011.
    >> Share

    January 2024
  16. AL HUSSEIN AL AWAMLH B, Wallis CJD, Penson DF, Huang LC, et al
    Functional Outcomes After Localized Prostate Cancer Treatment.
    JAMA. 2024;331:302-317.
    >> Share

    April 2023
  17. NIK-AHD F, De Hoedt A, Butler C, Anger JT, et al
    Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022.
    JAMA. 2023 Apr 29:e236028. doi: 10.1001/jama.2023.6028.
    >> Share

    March 2023
  18. HARRIS E
    Treatment Type Did Not Change Prostate Cancer Survival in UK Trial.
    JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4002.
    >> Share

    May 2022
  19. LARKIN HD
    Targeted Radioligand Approved for Metastatic Prostate Cancer.
    JAMA. 2022;327:1642.
    >> Share

    January 2022
  20. SLOMSKI A
    Some Men With Localized Prostate Cancer Regret Surgery.
    JAMA. 2022;327:26.
    >> Share

    November 2021
  21. SLOMSKI A
    High-Intensity Interval Training in Prostate Cancer.
    JAMA. 2021;326:1666.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016